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Abstract
A 56-year-old, non-smoker male with no exposure, presented with right chest pain and a huge loss in forced vital capacity
due to right lung volume reduction with consensual pleural thickening on high-resolution computed tomography. All
serological and microbiological tests were negative. The surgical lung biopsy showed fibrinous pleurisy while the search for
neoplastic cells resulted negative. Because of symptoms worsening he started low dose steroids without benefits until he
died 3 months later for cardiac ischemic attack. We reviewed the literature to identify possible etiologies and a rapidly
progressive idiopathic pleurisy revealed to be the most probable diagnosis.
INTRODUCTION
Here we present a case of idiopathic fibrinous pleurisy affecting
a 56-year-old non-smoker male that has shown a rapidly pro-
gressive course. Adding a brief review of literature, we discuss
the absence of any identified cause of pleurisy as a relatively
common condition, requiring attention and clinical awareness.
CASE REPORT
A 56-year-old non-smoker male, engineer for a gas company,
presented in early January 2017 with right chest pain and a
1.56 L (29.4%) loss in forced vital capacity (FVC) over the previ-
ous 3 years. The anamnestic investigation for professional
exposure including asbestos resulted negative. The physical
examination revealed the reduction of lung sounds at the right
lung basis while no clinical sign of autoimmune disease was
found. A chest X-ray (CXR) was performed and showed a
considerable reduction in the right lung volume with asso-
ciated right pleural effusion (Fig. 1). All serological, auto-
immune and microbiological tests resulted negative, so he
underwent plain and contrast enhanced computed tomography
(CT) that revealed a slight reduction in right lung volume with
associated right pleural effusion and pleural thickening (Fig. 2).
A supplemental investigation was conducted excluding history
of trauma, tuberculosis and pneumothorax. Echocardiography
excluded pulmonary hypertension. Diaphragm dysfunction
was also investigated through phrenic nerve stimulation, but
with a negative result. On March 2017 a total body positron
emission tomography–computed tomography (PET-CT) with 18-
FluoroDeoxyGlucose (18-FDG) was performed and revealed a
low intensity hyper-accumulation of 18-FDG in the right pleura
with increased concentration in the basal, middle and posterior
pleural surface. Thus, a surgical lung biopsy (SLB) was carried,
identifying a non-specific fibrinous pleurisy (Fig. 3). The search
for neoplastic or infectious cells resulted negative. PFTs
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Figure 2: High-resolution CT scan showing right pleural thickening (A). Coronal view clearly shows both right lung volume loss and intra-lobar pleural abnormalities (B).
Figure 1: Chest X-ray in antero-posterior (A) and lateral view (B) showing consistent reduction of the right lung with basal pleural effusion.
Figure 3: Histologic samples at different magnification of the video assisted pleural biopsy. (A and B) Show diffuse organized fibrosis with fibrinous exudates and little
sporadic amount of inflammatory cells. (C and D) Show fibroblasts with collagen deposition.
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performed 1 month later revealed further important drop in
FVC (2.5 L loss). The patient developed shortness of breath on
exertion, therefore, a prednisolone course (0.25mg/kg daily)
was started. However, PFTs persistently declined with the onset
of restrictive respiratory failure. The patient died 2 weeks later
for cardiac ischemic attack. Autopsy excluded mesothelioma or
other pleural neoplastic diseases, but reported the presence of
diffuse fibrinous pleurisy with collagen deposition.
DISCUSSION
Even after a comprehensive diagnostic work-up, a considerable
amount of patients with non-specific pleural exudates do not
receive a precise diagnosis [1–3]. The natural history of this
frustrating condition still remains poorly understood [1, 4].
With this case report we present the onset and evolution of
unilateral idiopathic fibrinous pleurisy, whose description
might contribute to better characterize the spectrum presenta-
tion of this peculiar condition.
The percentage of patients with persistent pleural effusion
in which diagnostic examinations—including VATS biopsy—do
not allow the identification of any etiology ranges from 10 to
25% [1–5]. Despite Gunluoglu et al. [6] demonstrated that a strict
follow-up period should help in formulating the diagnosis sug-
gesting a probable cause of the disease on clinical grounds, the
question on the real existence of chronic idiopathic pleurisy
still remains [7]. We thus performed a PubMed search using
‘idiopathic’, ‘non-specific’, ‘pleurisy’ and ‘chronic’ as key words
and a total amount of 10 works was found. A study by
Venekamp et al. [8] has shown that benign diseases, in particu-
lar heart failure and parapneumonic pleural effusion, were the
most frequently identified causes of chronic pleural effusion
evolving in fibrosis without no specific histological changes.
Different series have identified that pulmonary embolism and
drug-related effusion do not lead to definite histological
changes in the pleura [5, 8, 9]. In such cases, biopsy samples
obtained by VATS are not expected to be diagnostic [8].
Therefore, in these patients a thorough clinical assessment as
well as a precise investigation on past medical history and
voluptuary habits is mandatory. In particular, autoimmune dis-
eases should be carefully excluded as quite frequent ultimate
cause of isolated recurrent pleurisy [5]. An invasive diagnostic
procedure, such as the one performed in the presented case, is
indicated in cases in which malignancy is suspected and can-
not be excluded from a clinical or radiological point of view [10,
11]. When clinical data are silent and alternative causes have
been excluded, the identification of non-specific pleurisy
obtained on surgical lung specimen should prompt the diagno-
sis of idiopathic pleuritis and should not be considered a false
negative [12].
From data available in literature, the majority of cases pre-
senting with idiopathic pleurisy usually present a benign
course (up to 92%) [4, 7, 13]. Recurrence of effusion has been
reported in 17% of cases, while complete resolution was
described for the great majority of patients (82%) [8]. The clin-
ical presentation of our case seems peculiar due to the rapid
progression of the fibrinous process affecting the pleura with
dramatic impact on respiratory function tests, namely on FVC.
The biopsy proven benign nature of the fibrinous disease was
confirmed through autopsy thus excluding neoplastic disease.
As we were not able to identify any cause that could be con-
sidered responsible for this condition, a diagnosis of idiopathic
rapidly progressive pleurisy was made. The uncommon impact
on ventilatory capacity of the presented case should be
considered in the possible natural history of non-specific pleur-
al disease.
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